OverviewThe NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Breast Cancer: Noninvasive and Special Situations presented here are the work of the NCCN Breast Cancer panel members. Categories of evidence and consensus were assessed and are noted in the algorithms and text. Although not explicitly stated at every decision point of the guidelines, patient participation in prospective clinical trials is the preferred option of treatment for all stages of breast cancer. These NCCN Guidelines focus on noninvasive breast cancer and special situations, such as Paget's disease, phyllodes tumor, breast cancer during pregnancy, and axillary breast cancer. Another NCCN guideline addresses invasive breast cancer (see NCCN Clinical Practice Guidelines in Oncology [NCCN Guidelines] for Breast Cancer: Invasive and Inflammatory; to view the complete and most recent version of these guidelines, visit the NCCN Web site at www.NCCN.org).The American Cancer Society estimates that 194,280 new cases of invasive breast cancer were diagnosed and 40,610 died of the disease in the United States in 2009.1 In addition, approximately 62,280 women were diagnosed with carcinoma in situ of the breast during the same year. Breast cancer is the most common malignancy in women in the United States and is second only to lung cancer as a cause of cancer death.The incidence of breast cancer has increased steadily in the United States over the past few decades, but breast cancer mortality seems to be declining,1,2 suggesting a benefit from early detection and more effective treatment.The origin of most breast cancer...
  • 1.

    JemalASiegelRWardE. Cancer statistics, 2009. CA Cancer J Clin2009;59:225249.

  • 2.

    Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet2005;365:16871717.

    • Search Google Scholar
    • Export Citation
  • 3.

    GailMHCostantinoJPBryantJ. Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. J Natl Cancer Inst1999;91:18291846.

    • Search Google Scholar
    • Export Citation
  • 4.

    DupontWDPageDL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med1985;312:146151.

  • 5.

    GreeneFLPageDLFlemingID. AJCC Cancer Staging Manual 6th ed.New York, NY: Springer-Verlag; 2002.

  • 6.

    SingletarySEAllredCAshleyP. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol2002;20:36283636.

    • Search Google Scholar
    • Export Citation
  • 7.

    SingletarySEGreeneFLSobinLH. Classification of isolated tumor cells: clarification of the 6th edition of the American Joint Committee on Cancer Staging Manual. Cancer2003;98:27402741.

    • Search Google Scholar
    • Export Citation
  • 8.

    WhiteJMorrowMMoughanJ. Compliance with breast-conservation standards for patients with early-stage breast carcinoma. Cancer2003;97:893904.

    • Search Google Scholar
    • Export Citation
  • 9.

    WilkinsonNWShahryarinejadAWinstonJS. Concordance with breast cancer pathology reporting practice guidelines. J Am Coll Surg2003;196:3843.

    • Search Google Scholar
    • Export Citation
  • 10.

    AllredDCHarveyJMBerardoM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol1999;11:155168.

    • Search Google Scholar
    • Export Citation
  • 11.

    RhodesAJasaniBBarnesDM. Reliability of immunochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems. J Clin Pathol2000;53:125130.

    • Search Google Scholar
    • Export Citation
  • 12.

    RudigerTHöflerHKreipeHH. Quality assurance in immunohistochemistry: results of an interlaboratory trial involving 172 pathologists. Am J Surg Pathol2002;26:873882.

    • Search Google Scholar
    • Export Citation
  • 13.

    AllredDCCarlsonRWBerryDA. NCCN Task Force Report: estrogen receptor and progesterone receptor testing in breast cancer by immunohistochemistry. J Natl Compr Cancer Netw2009;7(Suppl 6):S124.

    • Search Google Scholar
    • Export Citation
  • 14.

    WangSSaboorianMHFrenkelE. Laboratory assessment of the status of Her-2/neu protein and oncogene in breast cancer specimens: comparison of immunohistochemistry assay with fluorescence in situ hybridisation assays. J Clin Pathol2000;53:374381.

    • Search Google Scholar
    • Export Citation
  • 15.

    DAKO HercepTest [package insert]. Carpinteria, CA: DAKO Corp; 2004.

  • 16.

    Pathway HER2 [package insert]. Tucson, AZ: Ventana Medical Systems, Inc; 2004.

  • 17.

    INFORM HER2/neu gene detection system [package insert]. Tucson, AZ: Ventana Medical Systems, Inc; 2001.

  • 18.

    Pathvysion HER2/neu method [package insert]. Downers Grove, IL: Vysis, Inc; 2001.

  • 19.

    HER2 FISH pharmDx Kit [package insert]. Glostrup, Denmark: Dako Denmark A/S; 2005.

  • 20.

    SPOT-Light HER2 CISH kit [package insert]Camarillo, CA: Invitrogen Corp; 2008.

  • 21.

    AndersonSGilkersonEKleinP. Concordance between local labs and a central lab using FISH and IHC for HER2 testing [abstract]. Breast Cancer Res Treat2002;76(Suppl 1):S68. Abstract 235.

    • Search Google Scholar
    • Export Citation
  • 22.

    PaikSBryantJTan-ChiuE. Real-world performance of HER2 testing—National Surgical Adjuvant Breast and Bowel Project experience. J Natl Cancer Inst2002;94:852854.

    • Search Google Scholar
    • Export Citation
  • 23.

    PaikSTan-ChiuEBryantJ. Successful quality assurance program for HER2 testing in the NSABP trial for Herceptin [abstract]. Breast Cancer Res and Treat2002;76(Suppl 1):S31. Abstract 9.

    • Search Google Scholar
    • Export Citation
  • 24.

    PerezEASumanVJDavidsonNE. HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 Intergroup adjuvant trial. J Clin Oncol2006;24:30323038.

    • Search Google Scholar
    • Export Citation
  • 25.

    TubbsRRPettayJDRochePC. Discrepancies in clinical laboratory testing of eligibility for trastuzumab therapy: apparent immunohistochemical false-positives do not get the message. J Clin Oncol2001;19:27142721.

    • Search Google Scholar
    • Export Citation
  • 26.

    PressMFSauterGBernsteinL. Diagnostic evaluation of HER-2 as a molecular target: an assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trials. Clin Cancer Res2005;11:65986607.

    • Search Google Scholar
    • Export Citation
  • 27.

    CarlsonRWMoenchSJHammondME. HER2 testing in breast cancer: NCCN task force report and recommendations. J Natl Compr Canc Netw2006;4(Suppl 3):S122.

    • Search Google Scholar
    • Export Citation
  • 28.

    WolffACHammondMESchwartzJN. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol2007;25:118147.

    • Search Google Scholar
    • Export Citation
  • 29.

    GiordanoSHValeroVBuzdarAUHortobagyiGN. Efficacy of anastrozole in male breast cancer. Am J Clin Oncol2002;25:235237.

  • 30.

    GiordanoSHBuzdarAUHortobagyiGN. Breast cancer in men. Ann Intern Med2002;137:678687.

  • 31.

    RosaiJ. Borderline epithelial lesions of the breast. Am J Surg Pathol1991;15:209221.

  • 32.

    SchnittSJConnollyJLTavassoliFA. Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria. Am J Surg Pathol1992;16:11331143.

    • Search Google Scholar
    • Export Citation
  • 33.

    HaagensenCDBodianCHaagensenDEJr. Breast carcinoma. Risk and Detection. Philadelphia, PA: W.B. Saunders; 1981.

  • 34.

    BradleySJWeaverDWBouwmanDL. Alternatives in the surgical management of in situ breast cancer. A meta-analysis of outcome. Am Surg1990;56:428432.

    • Search Google Scholar
    • Export Citation
  • 35.

    ChubaPJHamreMRYapJ. Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data. J Clin Oncol2005;23:55345541.

    • Search Google Scholar
    • Export Citation
  • 36.

    AndersonBOCalhounKERosenEL. Evolving concepts in the management of lobular neoplasia. J Natl Compr Canc Netw2006;4:511522.

  • 37.

    FisherBCostantinoJPWickerhamDL. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst1998;90:13711388.

    • Search Google Scholar
    • Export Citation
  • 38.

    FisherBCostantinoJPWickerhamDL. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst2005;97:16521662.

    • Search Google Scholar
    • Export Citation
  • 39.

    VogelVGCostantinoJPWickerhamDL. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA2006;295:27272741.

    • Search Google Scholar
    • Export Citation
  • 40.

    VargasCKestinLGoN. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy. Int J Radiat Oncol Biol Phys2005;63:15141521.

    • Search Google Scholar
    • Export Citation
  • 41.

    BijkerNMeijnenPPeterseJL. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853—a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol2006;24:33813387.

    • Search Google Scholar
    • Export Citation
  • 42.

    FisherBDignamJWolmarkN. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol1998;16:441452.

    • Search Google Scholar
    • Export Citation
  • 43.

    JulienJPBijkerNFentimanIS. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. Lancet2000;355:528533.

    • Search Google Scholar
    • Export Citation
  • 44.

    EmdinSOGranstrandBRingbergA. SweCDIS: radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomized trial in a population offered mammography screening. Acta Oncol2006;45:536543.

    • Search Google Scholar
    • Export Citation
  • 45.

    HoughtonJGeorgeWDCuzickJ. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Austraila, and New Zealand: randomised controlled trial. Lancet2003;362:95102.

    • Search Google Scholar
    • Export Citation
  • 46.

    HolmbergLGarmoHGranstrandB. Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast. J Clin Oncol2008;26:12471252.

    • Search Google Scholar
    • Export Citation
  • 47.

    SilversteinMJLagiosMDCraigPH. A prognostic index for ductal carcinoma in situ of the breast. Cancer1996;77:22672274.

  • 48.

    SilversteinMJLagiosMDGroshenS. The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med1999;340:14551461.

    • Search Google Scholar
    • Export Citation
  • 49.

    Di SaverioSCatenaFSantiniD. 259 patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up. Breast Cancer Res Treat2008;109:405416.

    • Search Google Scholar
    • Export Citation
  • 50.

    GilleardOGoodmanACooperM. The significance of the Van Nuys prognostic index in the management of ductal carcinoma in situ. World J Surg Oncol2008;6:61.

    • Search Google Scholar
    • Export Citation
  • 51.

    HughesLLWangMPageDL. Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol2009;27:53195324.

    • Search Google Scholar
    • Export Citation
  • 52.

    HughesLLWangMPageDL. Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol2009;27:53195324.

    • Search Google Scholar
    • Export Citation
  • 53.

    MacDonaldHRSilversteinMJMabryH. Local control in ductal carcinoma in situ treated by excision alone: incremental benefit of larger margins. Am J Surg2005;190:521525.

    • Search Google Scholar
    • Export Citation
  • 54.

    DunneCBurkeJPMorrowMKellMR. Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. J Clin Oncol2009;27:16151620.

    • Search Google Scholar
    • Export Citation
  • 55.

    JulianTBLandSRFourchotteV. Is sentinel node biopsy necessary in conservatively treated DCIS?Ann Surg Oncol2007;14:22022208.

  • 56.

    EdgeSBSheldonDG. Counterpoint: sentinel lymph node biopsy is indicated for ductal carcinoma in situ. J Natl Compr Canc Netw2003;1:207212.

    • Search Google Scholar
    • Export Citation
  • 57.

    CodyHSIIIVan ZeeKJ. Point: sentinel lymph node biopsy is indicated for ductal carcinoma in situ. J Natl Compr Canc Netw2003;1:199206.

    • Search Google Scholar
    • Export Citation
  • 58.

    LymanGHGiulianoAESomerfieldMR. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol2005;23:77037720.

    • Search Google Scholar
    • Export Citation
  • 59.

    WaddellBEStomperPCDeFazioJL. Postexcision mammography is indicated after resection of ductal carcinoma-in-situ of the breast. Ann Surg Oncol2000;7:665668.

    • Search Google Scholar
    • Export Citation
  • 60.

    Tan-ChiuEWangJCostantinoJP. Effects of tamoxifen on benign breast disease in women at high risk for breast cancer. J Natl Cancer Inst2003;95:302307.

    • Search Google Scholar
    • Export Citation
  • 61.

    FisherBDignamJWolmarkN. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet1999;353:19932000.

    • Search Google Scholar
    • Export Citation
  • 62.

    AllredDBryantJLandS. Estrogen receptor expression as a predictive marker of the effectiveness of tamoxifen in the treatment of DCIS: Findings from NSABP Protocol B-24 [abstract]. Breast Cancer Res Treat2003;76(Suppl 1):Abstract 30.

    • Search Google Scholar
    • Export Citation
  • 359.

    SakorafasGHBlanchardKSarrMGFarleyDR. Paget's disease of the breast. Cancer Treat Rev2001;27:918.

  • 360.

    MarcusE. The management of Paget's disease of the breast. Curr Treat Options Oncol2004;5:153160.

  • 361.

    KollmorgenDRVaranasiJSEdgeSBCarsonWEIII. Paget's disease of the breast: a 33-year experience. J Am Coll Surg1998;187:171177.

  • 362.

    MorroghMMorrisEALibermanL. MRI identifies otherwise occult disease in select patients with Paget's disease of the nipple. J Am Coll Surg2008;206:316321.

    • Search Google Scholar
    • Export Citation
  • 363.

    FreiKABonelHMPelteMF. Paget disease of the breast: findings at magnetic resonance imaging and histopathologic correlation. Invest Radiol2005;40:363367.

    • Search Google Scholar
    • Export Citation
  • 364.

    PierceLJHafftyBGSolinLJ. The conservative management of Paget's disease of the breast with radiotherapy. Cancer1997;80:10651072.

  • 365.

    SinghASuttonRJBakerCBSacksNP. Is mastectomy overtreatment for Paget's disease of the nipple?Breast1999;8:191194.

  • 366.

    BijkerNRutgersEJDuchateauL. Breast-conserving therapy for Paget disease of the nipple: a prospective European Organization for Research and Treatment of Cancer study of 61 patients. Cancer2001;91:472477.

    • Search Google Scholar
    • Export Citation
  • 367.

    KawaseKDimaioDJTuckerSL. Paget's disease of the breast: there is a role for breast-conserving therapy. Ann Surg Oncol2005;12:391397.

    • Search Google Scholar
    • Export Citation
  • 368.

    MarshallJKGriffithKAHafftyBG. Conservative management of Paget disease of the breast with radiotherapy: 10- and 15-year results. Cancer2003;97:21422149.

    • Search Google Scholar
    • Export Citation
  • 369.

    MarshallJKGriffithKAHafftyBG. Conservative management of Paget disease of the breast with radiotherapy: 10- and 15-year results. Cancer2003;97:21422149.

    • Search Google Scholar
    • Export Citation
  • 370.

    LarongaCHassonDHooverS. Paget's disease in the era of sentinel lymph node biopsy. Am J Surg2006;192:481483.

  • 371.

    SukumvanichPBentremDJCodyHSIII. The role of sentinel lymph node biopsy in Paget's disease of the breast. Ann Surg Oncol2007;14:10201023.

    • Search Google Scholar
    • Export Citation
  • 372.

    TelliMLHorstKCGuardinoAR. Phyllodes tumors of the breast: natural history, diagnosis, and treatment. J Natl Compr Canc Netw2007;5:324330.

    • Search Google Scholar
    • Export Citation
  • 373.

    AndersonBOLawtonTJLehmanCDMoeRE. Phyllodes tumors. In: HarrisJRLippmanMEMorrowMOsborneCK eds. Diseases of the Breast 3rd ed.Philadelphia, PA: Lippincott Williams & Wilkins; 2004:991206.

    • Search Google Scholar
    • Export Citation
  • 374.

    SalvadoriBCusumanoFDel BoR. Surgical treatment of phyllodes tumors of the breast. Cancer1989;63:25322536.

  • 375.

    BirchJMAlstonRDMcNallyRJ. Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene2001;20:46214628.

    • Search Google Scholar
    • Export Citation
  • 376.

    ChaneyAWPollackAMcNeeseMD. Primary treatment of cystosarcoma phyllodes of the breast. Cancer2000;89:15021511.

  • 377.

    MangiAASmithBLGaddMA. Surgical management of phyllodes tumors. Arch Surg1999;134:487492.

  • 378.

    PandeyMMathewAKattoorJ. Malignant phyllodes tumor. Breast J2001;7:411416.

  • 379.

    TseGMLeeCSKungFY. Hormonal receptors expression in epithelial cells of mammary phyllodes tumors correlates with pathologic grade of the tumor: a multicenter study of 143 cases. Am J Clin Pathol2002;118:522526.

    • Search Google Scholar
    • Export Citation
  • 380.

    SmithLHDalrympleJLLeiserowitzGS. Obstetrical deliveries associated with maternal malignancy in California, 1992 through 1997. Am J Obstet Gynecol2001;184:15041512.

    • Search Google Scholar
    • Export Citation
  • 381.

    MiddletonLPAminMGwynK. Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features. Cancer2003;98:10551060.

    • Search Google Scholar
    • Export Citation
  • 382.

    GwynKTheriaultR. Breast cancer during pregnancy. Oncology (Williston Park)2001;15:3946.

  • 383.

    YangWTDrydenMJGwynK. Imaging of breast cancer diagnosed and treated with chemotherapy during pregnancy. Radiology2006;239:5260.

  • 384.

    KuererHMGwynKAmesFCTheriaultRL. Conservative surgery and chemotherapy for breast carcinoma during pregnancy. Surgery2002;131:108110.

    • Search Google Scholar
    • Export Citation
  • 385.

    AnnaneKBellocqJPBrettesJPMathelinC. Infiltrative breast cancer during pregnancy and conservative treatment. Fetal Diagn Ther2005;20:442444.

    • Search Google Scholar
    • Export Citation
  • 386.

    KheraSYKilukJVHassonDM. Pregnancy-associated breast cancer patients can safely undergo lymphatic mapping. Breast J2008;14:250254.

  • 387.

    MondiMMCuencaREOllilaDW. Sentinel lymph node biopsy during pregnancy: initial clinical experience. Ann Surg Oncol2007;14:218221.

  • 388.

    FilippakisGMZografosG. Contraindications of sentinel lymph node biopsy: are there any really?World J Surg Oncol2007;29;5:10.

  • 389.

    KeleherAWendtRIIIDelpassandE. The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99m sulfur colloid. Breast J2004;10:492495.

    • Search Google Scholar
    • Export Citation
  • 390.

    GentiliniOCremonesiMTrifiroG. Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol2004;15:13481351.

  • 391.

    Pandit-TaskarNDauerLTMontgomeryL. Organ and fetal absorbed dose estimates from 99mTc-sulfur colloid lymphoscintigraphy and sentinel node localization in breast cancer patients. J Nucl Med2006;47:12021208.

    • Search Google Scholar
    • Export Citation
  • 392.

    GermannNGoffinetFGoldwasserF. Anthracyclines during pregnancy: embryo-fetal outcome in 160 patients. Ann Oncol2004;15:146150.

  • 393.

    JohnsonPHGwynKGordonN. The treatment of pregnant women with breast cancer and the outcomes of the children exposed to chemotherapy in utero [abstract]. J Clin Oncol2005;23(Suppl 1):Abstract 540.

    • Search Google Scholar
    • Export Citation
  • 394.

    DollDCRingenbergQSYarbroJW. Antineoplastic agents and pregnancy. Semin Oncol1989;16:337346.

  • 395.

    EbertULofflerHKirchW. Cytotoxic therapy and pregnancy. Pharmacol Ther1997;74:207220.

  • 396.

    HahnKMJohnsonPHGordonN. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer2006;107:1219.

    • Search Google Scholar
    • Export Citation
  • 397.

    Gonzalez-AnguloAMWaltersRSCarpenterRJJr. Paclitaxel chemotherapy in a pregnant patient with bilateral breast cancer. Clin Breast Cancer2004;5:317319.

    • Search Google Scholar
    • Export Citation
  • 398.

    PotluriVLewisDBurtonGV. Chemotherapy with taxanes in breast cancer during pregnancy: case report and review of the literature. Clin Breast Cancer2006;7:167170.

    • Search Google Scholar
    • Export Citation
  • 399.

    GainfordMClemonsM. Breast cancer in pregnancy: are taxanes safe?Clin Oncol2006;18:159.

  • 400.

    MirOBerveillerPRopertS. Emerging therapeutic options for breast cancer chemotherapy during pregnancy. Ann Oncol2008;19:607613.

  • 401.

    Garcia-ManeroMRoyoMPEspinosJ. Pregnancy associated breast cancer. Eur J Surg Oncol35:215218.

  • 402.

    FanaleMAUyeiARTheriaultRL. Treatment of metastatic breast cancer with trastuzumab and vinorelbine during pregnancy. Clin Breast Cancer2005;6:354356.

    • Search Google Scholar
    • Export Citation
  • 403.

    WatersonAMGrahamJ. Effect of adjuvant trastuzumab on pregnancy. J Clin Oncol2006;24:321322.

  • 404.

    WatsonWJ. Herceptin (trastuzumab) therapy during pregnancy: association with reversible anhydramnios. Obstet Gynecol2005;105:642643.

    • Search Google Scholar
    • Export Citation
  • 405.

    SekarRStonePR. Trastuzumab use for metastatic breast cancer in pregnancy. Obstet Gynecol2007;110:507510.

  • 406.

    BaderAASchlembachDTamussinoKF. Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy. Lancet Oncol2007;8:7981.

    • Search Google Scholar
    • Export Citation
  • 407.

    PantSLandonMBBlumenfeldM. Treatment of breast cancer with trastuzumab during pregnancy. J Clin Oncol2008;26:15671569.

  • 408.

    WitzelIDMuellerVHarpsE. Trastuzumab in pregnancy associated with poor fetal outcome. Ann Oncol2007;19:191195.

  • 409.

    ShrimAGarcia-BournissenFMaxwellC. Favorable pregnancy outcome following trastuzumab (Herceptin) use during pregnancy—case report and updated literature review. Reprod Toxicol2007;23:611613.

    • Search Google Scholar
    • Export Citation
  • 410.

    KellyHGrahamMHumesE. Delivery of a healthy baby after first-trimester maternal exposure to lapatinib. Clin Breast Cancer2006;7:339341.

    • Search Google Scholar
    • Export Citation
  • 430.

    BlanchardDKShettyPBHilsenbeckSGElledgeRM. Association of surgery with improved survival in stage IV breast cancer patients. Ann Surg2008;247:732738.

    • Search Google Scholar
    • Export Citation
  • 431.

    VaradarajanREdgeSBYuJ. Prognosis of occult breast carcinoma presenting as isolated axillary nodal metastasis. Oncology2006;71:456459.

    • Search Google Scholar
    • Export Citation
  • 432.

    OlsonJAMorrisEAVan ZeeKJ. Magnetic resonance imaging facilitates breast conservation for occult breast cancer. Ann Surg Oncol2000;7:411415.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 260 260 26
PDF Downloads 38 38 7
EPUB Downloads 0 0 0